Evolent Health Inc.

NYSE: EVH · Real-Time Price · USD
9.09
0.27 (3.06%)
At close: Aug 15, 2025, 12:18 PM

Evolent Health Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-61.62M -113.04M -19.16M -37.6M
Depreciation & Amortization
125.61M 123.42M 67.19M 60.04M
Stock-Based Compensation
39.75M 40.5M 33.98M 16.71M
Other Working Capital
-152.87M 193.31M -14.63M -1M
Other Non-Cash Items
34.4M 101.09M 10.53M 13.77M
Deferred Income Tax
-2.82M -31.27M 342K -526K
Change in Working Capital
-116.56M 21.89M -104.44M -13.64M
Operating Cash Flow
18.77M 142.58M -11.55M 38.75M
Capital Expenditures
-24.89M -28.75M -38.36M -24.98M
Cash Acquisitions
n/a n/a 5.55M -34.79M
Purchase of Investments
-7.32M n/a -5.55M -3M
Sales Maturities Of Investments
n/a n/a 5.55M 500K
Other Investing Acitivies
-30.72M -386.8M -226.31M 46.49M
Investing Cash Flow
-62.93M -415.54M -259.12M -15.79M
Debt Repayment
58.58M 183.29M 160.29M -37.69M
Common Stock Repurchased
n/a -15.29M -18.32M -3.85M
Dividend Paid
-20.09M -18.79M -14.88M -1.3M
Other Financial Acitivies
-42.52M -63.68M -18.32M -3.85M
Financial Cash Flow
-565K 281.34M 131.54M -29.55M
Net Cash Flow
-44.96M 8.3M -139.78M -6.64M
Free Cash Flow
-6.13M 113.84M -49.91M 13.76M